Fasten your seatbelts because this semester brings an exceptional seminar series! 🤩 We have an amazing lineup of speakers for this seminar season at @biumedicine. 🤯🤯🤯
Excited and honored to receive the @ERC_Research Advanced Grant 🤯🥳🙏
Deciphering the molecular mechanisms of the sophisticated #mucus hydrogels - we are just getting started 💪💪💪
📢 The ERC Advanced Grants competition results are out. Over €544 million in funding for leading researchers.
All info ➡️ https://t.co/doDRyBRrzZ
@EUScienceInnov 🇪🇺#EUfunded#FrontierResearch#AdG
[🧵#thread 1 of 4]
Very excited to share our recent cool story!
Commensal microbiota from patients with inflammatory bowel disease produce genotoxic metabolites https://t.co/5zqDS9TX3Z
Congratulations to @DapingYang88 and lab members on our recent work, now on the cover of @CellCellPress!
Glad to have this work out and excited to continue studying how neurons regulate barrier function and #immunology in the #gut and other sites
https://t.co/EaxLQgl2bA
New paper alert 🥳! Happy to share new study on epigenetic rewiring of CAFs @CR_AACR Global DNA Methylation Analysis of Cancer-Associated Fibroblasts Reveals Extensive Epigenetic Rewiring Linked with RUNX1 Upregulation in Breast Cancer Stroma! https://t.co/Ro8Je5ivus 1/6
Our recent review about #Disulfide Bond Formation and #Redox Regulation in the #Golgi
🟡Disulfide catalyst QSOX1 regulates Golgi glycosyltransferases
🟡Disulfide-mediated multimerization events in the Golgi are QSOX1 independent
🟡and more..!
https://t.co/XVHsrwYleH
#NatMetabPicks | In @CellCellPress, the @FassLab (@WeizmannScience) reveals a protective role of intestinal mucus, which prevents copper-related #toxicity through intestinal mucin, by acting as an extracellular copper chaperone.
https://t.co/Mg6XRzBMCj
So glad to share the fantastic work done by our own Dr. @ilani_tal 👏
Now out @embojournal -
"The disulfide catalyst QSOX1 maintains the colon mucosal barrier by regulating Golgi glycosyltransferases"
https://t.co/58J140Wohi